|
Thanks to SoCalBio Partner
| |
|
|
Thanks to SoCalBio Weekly Update Sponsor
|
Recommended Events
January 23 - 24, 2012
Computer History Museum, Silicon Valley
******************** 
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
December 5, 2011 
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
| Biotech Growth in Los Angeles | |
LaSalle's Life Sciences Cluster Report Ranks Los Angeles Fourth in the US
 The report contends that Los Angeles' vast number of hospitals, universities and research facilities and its large college-educated population should help propel the region's growing biotechnology sector to complement its mature medical device presence ... Read more
|
| MedTech Growth | |
Medtech Sector Poised for Growth Despite
Regulatory Hurdles
 IBISWorld, the largest publisher of industry research in the US, released a study indicating that overall, the medtech industry should see an increase in revenues because it will increase the number of insured by a significant amount. Revenue is projected to increase by 7.4 percent in 2012 and at an average annual rate of 6.4 percent during the next five years to 2016, reaching to $82.1 billion. However, the Medtech sector's profitability may suffer as a result of the Patient Protection and Affordable Care Act of 2010 and the med device tax ... Read more
|
| Events | |
SoCalBio Offers an Executive Luncheon in Orange County Focused on
Reimbursement Strategies in a Changing
Healthcare System
December 15, 11:30 to 1:30
Omnica (Irvine CA)
 | |
Judy Rosenbloom President JR Associates Inc.
|
This by-invitation-only luncheon & Roundtable is solely for solid peer-to-peer information exchange and debate. The roundtable is open to SoCalBio member companies and invited executives affiliated with non-member companies. Our speaker is Judy Rosenbloom (photo right), a highly recognized expert on payer policies and regulations who understands how to link the clinical benefits of medical technology with today's reimbursement environment. Leveraging her rich experience as an entrepreneur, clinical operations manager and allied health practitioner, Ms Rosenbloom develops creative solutions to reimbursement's most complex challenges - including the pursuit of coverage as well as CPT, HCPCS, ICD-9 codes... Learn more
Recommended Event
Taiwan: Partnering with you in Biotech
and Medical Devices
Hilton LA/San Gabriel (225 West Valley Blvd, San Gabriel, CA)
A Taiwanese delegation, led by Mr. Jung-Chiou, Hwang, Vice Minister of the Ministry of Economic Affairs, will introduce to the U.S. business community the various opportunities for collaboration with Taiwanese counterparts. SoCalBio supports this event as it promotes networking and opens avenues for communication leading to future collaborative projects and mutually beneficial exchanges .. Click here for agenda and to RSVP now (free event)
|
| Meet New SoCalBio Member Companies | |
Neumedicines (Pasadena)
 Neumedicines Inc. is a privately held drug discovery and development company focused on innovative protein therapies for the treatment of hematopoietic deficiencies and cancer. Neumedicines has recently signed a contract worth up to $273 million to fund advanced development of its HemaMax (recombinant human interleukin 12; rhuIL-12) for treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HSARS). The contract was awarded on September 15, 2011 by the Biomedical Advanced Research & Development Authority (BARDA) of the U.S. Department of Health and Human Services (DHHS) .... Learn more
SMRT Therapeutics (Los Angeles)
 | |
Dr. Richard Gatti
|
SMRT is a UCLA spinoff and winner of the UCLA Business of Science Center's business plan competition held last September and sponsored by the law firm of Perkins Coie. SMRT seeks to develop small molecules for treating genetic diseases. These molecules were discovered at the laboratory of Dr. Richard Gatti, Professor of Pathology and Laboratory Medicine, Geffen School of Medicine at UCLA.
Fox Rothschild (Los Angeles)
 Fox Rothschild delivers a full range of legal services - from the traditional (Litigation, Corporate, Labor and Employment) to the emerging services (Intellectual Property and Tech and Venture Finance). The firm has more than 500 lawyers in 16 offices throughout the US. Fox Rothschild is represented in SoCalBio by attorney Lisa Karczewski ... Learn more
Siegal Consulting (Pasadena)
Siegal Consulting provides business development analysis, in-licensing and new product commercial analysis and planning based on international and US experience. The company is represented in SoCalBio by Its founder Carolyn Siegal .... Learn more
|
| Interview | |
Interview With ImmunoCellular's Scientific Founder, Dr. John Yu, on the Potential For a Cancer Vaccine
 Dr. John Yu, M.D., Chairman and Chief Scientific Officer of ImmunoCellular Therapeutics, Ltd. (IMUC.OB) in Woodland Hills discusses the uniqueness of the company's brain cancer vaccine technology and its commercialization strategy ... Read interview at Seeking Alpha
|
| Studies | |
AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
Research sponsored by the Irvine-based company demonstrated that dietary supplementation of AHRO-001 resulted in a 95% reduction in arterial plaque formation at the innominate artery when compared to the control group. The study results also revealed significant reduction in plasma cholesterol and dietary cholesterol absorption in the test subjects that received HDCA. HDCA supplementation also improved HDL function as measured by cholesterol efflux assay. These factors indicate multiple methods of action for an anti-atherogenic effect, suggesting a clear potential for new anti-atherosclerotic therapy... Read more
|
| Financing | |
AcuFocus Raises $65 Million
 The Irvine-based AcuFocus Inc. raised $65 million in investments and equity financing in support of its Kamra corneal inlay treatment for near vision loss, or presbyopia. The Kamra device is already on the market in areas in Europe, Asia-Pacific, the Middle East and South America, according to a press release ... Read more
|
| IPO | |
Shotgun IPO Could Spell Trouble For Applied Medical
The Rancho Santa Margarita-based medical device company filed paperwork to sell some 6.4 million shares of its common stock on the over-the-counter Bulletin Board, saying it is being compelled by one of its main investors, Institutional Venture Partners, which wants to provide liquidity to its limited partners, according to the filing. Company executives and board members believe the move will set the company back, and only yield nominal returns to investors... Read more
|
| Product Approval | |
STAAR Surgical's Visian Toric ICL Approved to Market in Japan
 The Monrovia-based company's Visian ICL is the market share leader amongst all phakic IOLs and over a quarter of a million ICLs have been successfully implanted. The Visian ICL and Toric ICL are marketed in over 50 countries today. This approval of the Toric ICL in Japan means the U.S. is the only major market in the world where approval is still pending ... Read more
|
Jobs Available
| |
Neumedicines (Pasadena)
Chromologic (Pasadena)
Gilead (San Dimas)
C3 Jian (Inglewood)
Keck Graduate Institute (Claremont)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
